Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
FreeIn Brief

Baylor researchers receive five-year, $5.5M NCI grant for liver cancer risk factors and prevention research

August 05, 2022
Vol.48 No.31
Monica Bertagnolli, first woman and first clinical trials group chair to direct the National Cancer Institute
FreeWhite House

Monica Bertagnolli, first woman and first clinical trials group chair to direct the National Cancer Institute

July 21, 2022
Vol.48 No.29
By Paul Goldberg and Matthew Bin Han Ong
NIH-funded institutions must report sexual misconduct cases within 30 days, effective July 9
Capitol Hill

NIH-funded institutions must report sexual misconduct cases within 30 days, effective July 9

July 15, 2022
Vol.48 No.28
By Matthew Bin Han Ong
Shikha Jain, Shea Holman examine NIH’s new requirements for institutions to report misconduct
Capitol HillConversation with The Cancer Letter

Shikha Jain, Shea Holman examine NIH’s new requirements for institutions to report misconduct

July 15, 2022
Vol.48 No.28
By Matthew Bin Han Ong
Clinical Roundup

NCI study: Interferon may reduce severity of COVID-19 in people with genetic factors

July 15, 2022
Vol.48 No.28
Clinical Roundup

NCI study: COVID-19 was third leading cause of death in the U.S. in 2020 and 2021

July 08, 2022
Vol.48 No.27
NCI strategy for evaluating MCED assays may bypass cancer clinical trials groups

NCI strategy for evaluating MCED assays may bypass cancer clinical trials groups

June 24, 2022
Vol.48 No.25
By Paul Goldberg and Alice Tracey
NCI BSA approves eight new, nine reissued concepts

NCI BSA approves eight new, nine reissued concepts

June 24, 2022
Vol.48 No.25
By Alice Tracey
Julie Bauman: Washington, DC, needs one more NCI-designated cancer center­—and it matters that a woman runs it
Conversation with The Cancer Letter

Julie Bauman: Washington, DC, needs one more NCI-designated cancer center­—and it matters that a woman runs it

June 17, 2022
Vol.48 No.24
By Paul Goldberg
NCI, CRUK award $100M in Cancer Grand Challenge grants

NCI, CRUK award $100M in Cancer Grand Challenge grants

June 17, 2022
Vol.48 No.24
By Alice Tracey

Posts navigation

Previous1…303132…38Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • CBER Director Vinay Prasad dared to “say no to drugs”
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account